BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 10089768)

  • 1. [The treatment of diabetic nephropathy. The need for an early diagnosis].
    Teruel Briones JL
    Rev Clin Esp; 1999 Jan; 199(1):1-3. PubMed ID: 10089768
    [No Abstract]   [Full Text] [Related]  

  • 2. Why patients with diabetes, hypertension and/or proteinuria are not on angiotensin converting enzyme inhibitors.
    Gordian ME; Kelly J
    Alaska Med; 1998; 40(3):51-4. PubMed ID: 9785612
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prediction, screening and treatment of renal complications of diabetes].
    Marre M; Larger E
    Rev Prat; 2001 Oct; 51(16):1769-75. PubMed ID: 11795120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes and ACE inhibitors.
    Boulton AJ; Gokal R
    J Hum Hypertens; 1990 Oct; 4 Suppl 4():63-6; discussion 66-7. PubMed ID: 2283656
    [No Abstract]   [Full Text] [Related]  

  • 5. Reducing complications in type 2 diabetes.
    Poirier SJ
    Am Fam Physician; 1998 Mar; 57(6):1238-9. PubMed ID: 9531907
    [No Abstract]   [Full Text] [Related]  

  • 6. [Microalbuminuria as a warning sign of diabetic nephropathy. Test your diabetics early!].
    Dietrich W; Blumenstein M
    MMW Fortschr Med; 2003 Mar; 145(10):40-2. PubMed ID: 12688026
    [No Abstract]   [Full Text] [Related]  

  • 7. [Angiotensin-converting enzyme inhibitors in the treatment of diabetic nephropathy].
    Sawicki PT; Mühlhäuser I; Berger M
    Dtsch Med Wochenschr; 1994 Sep; 119(38):1298-9. PubMed ID: 7924925
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hypertension and diabetic nephropathy, a dangerous duo].
    Hausberg M; Hohage H; Kosch M
    Med Klin (Munich); 2005 Nov; 100(11):729-37; quiz 738-9. PubMed ID: 16328181
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening and treatment of diabetic renal disease.
    Clement JD; Cottiero RA
    Med Health R I; 1998 Nov; 81(11):348-9. PubMed ID: 15580788
    [No Abstract]   [Full Text] [Related]  

  • 10. [Renal histopathology of diabetic nephropathy].
    Suzuki Y
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():314-9. PubMed ID: 15999726
    [No Abstract]   [Full Text] [Related]  

  • 11. Reducing renal disease in diabetes.
    Mason P; Gerntholtz T
    Practitioner; 2001 Jun; 245(1623):557-61. PubMed ID: 11436266
    [No Abstract]   [Full Text] [Related]  

  • 12. [Nephropathy in type-1 diabetes].
    Sawicki PT; Berger M
    Dtsch Med Wochenschr; 1993 Mar; 118(9):319-21. PubMed ID: 8444117
    [No Abstract]   [Full Text] [Related]  

  • 13. [The early diagnosis of kidney failure in diabetic patients and the new developments in its treatment].
    Eliseev OM
    Ter Arkh; 1995; 67(4):66-9. PubMed ID: 7784984
    [No Abstract]   [Full Text] [Related]  

  • 14. [Angiotensin converting enzyme inhibitors in the treatment of diabetes].
    Smahelová A
    Vnitr Lek; 2003 Dec; 49(12):948-51. PubMed ID: 15040161
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors.
    Crook ED; Preddie DC
    Ethn Dis; 2002; 12(4):S3-49-52. PubMed ID: 12477155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic nephropathy: introduction.
    Breyer MD
    Semin Nephrol; 2007 Mar; 27(2):129. PubMed ID: 17418681
    [No Abstract]   [Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus.
    Hughes DB; Britton ML
    Pharmacotherapy; 2005 Nov; 25(11):1602-20. PubMed ID: 16232022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical studies on chronic diabetic nephropathy and recent data concerning prevention of risks of nephropathy and cardiovascular diseases].
    Esnault V
    Nephrol Ther; 2006 May; 2 Suppl 3():S193-6. PubMed ID: 17370850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating proteinuria in a diabetic patient despite hyperkalaemia due to hyporeninaemic hypoaldosteronism.
    van Nieuwkoop C; Ijpelaar DH; Bolk JH
    Neth J Med; 2007 Feb; 65(2):75-7. PubMed ID: 17379933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.